74 results
Page 3 of 4
8-K
EX-99.1
biy4ra8
10 Mar 21
Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for Company’s lead candidate, ADI-001, is believed to be the first IND-cleared allogeneic
7:30am
8-K
EX-1.1
qvu0h 2ktpe
16 Feb 21
Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
4:01pm
424B5
7ssvyb
11 Feb 21
Prospectus supplement for primary offering
5:20pm
424B5
g9kg419r
10 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
nvxwjr762
1 Dec 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
wq851r
22 Oct 20
Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
7:15am
424B5
uw9x3dtg 69wfzsq6kn
21 Sep 20
Prospectus supplement for primary offering
7:58am
8-K
EX-99.1
dbthjsnpkv21 b208
18 Sep 20
Management Following the Merger
4:30pm
8-K
EX-10.2
fmmn6 zd86
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.1
k6jlyo1bzf4gjfi
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.3
292 u7y4dfrm4h
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.4
qqt24zhv
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.2
rhszs
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.5
tx6g69lvz7rlnn
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.6
jllet 93fri4
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-10.13
r72k8
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
424B3
c1otm
21 Aug 20
Prospectus supplement
8:36am